Page 11 - மருத்துவ பாதுகாப்பு ஆஃப் புதுமையானது தொழில்நுட்பம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
CytoSorbents Announces 2020 Financial and Operational Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
CytoSorbents Announces 2020 Financial and Operational Results
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
CytoSorbents Announces 2020 Financial and Operational Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
TRADING UPDATES: PPHE Hotel crushed by pandemic; Renalytix excited
Tue, 2nd Mar 2021 18:14
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
JPMorgan Emerging Markets Investment Trust PLC - investment trust - Net asset value per share ends 2020 at 135.0 pence compared to 108.9p at end of June. NAV total return in first half 24.9%, beating benchmark, the MSCI Emerging Markets Index, which gains 18.5% in same period. Investment manager notes recovery of markets in final six months of 2020. Austin Forey adds: Although the situation remained severe in many countries, progress on vaccine development also offered hope that the pandemic will eventually pass. Against this background, it may seem strange to see equity markets reaching new highs; yet share prices are determined by investors making forward-looking judgements, and have therefore reflected the economic recovery and the ending of
Share this article
Share this article
PORTLAND, Ore., Feb. 23, 2021 /PRNewswire/ Inovise Medical today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for its AUDICOR
® heart failure management system. The system uses clinically tested algorithms to detect the risk of decompensation at home in patients who have been previously hospitalized for heart failure.
Inovise Medical, Inc.
Michael Mirro, MD, Director of the Parkview Mirro Center for Research and Innovation, and Clinical Professor of Medicine at Indiana University, commented, This technology promises to enhance the management of heart failure patients and keep them out of the hospital. Early detection of potential problems outside of the hospital can allow clinicians to modify the patients therapeutic regimens and maintain their stable condition.